Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.00
Bid: 130.00
Ask: 140.00
Change: 0.00 (0.00%)
Spread: 10.00 (7.692%)
Open: 135.00
High: 135.00
Low: 135.00
Prev. Close: 135.00
MANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Oct 2021 07:00

RNS Number : 0774O
Manolete Partners PLC
06 October 2021
 

06 October 2021

 

MANOLETE PARTNERS PLC

 

("Manolete" or the "Company")

Trading Update

 

In June 2020 the UK Government reacted to the Covid-19 pandemic by suppressing UK insolvencies through the use of various "Temporary Measures" contained in the Corporate Insolvency and Governance Act 2020. These measures largely ended, effective from 1 October 2021 as did a number of other business support schemes, including furlough. Manolete's trading for the interim six-month reporting period ended 30 September 2021 was during the time that these "Temporary Measures" were in full effect. Despite these unprecedented restrictions, the Company has performed well and in line with the Board's expectations during the period.

During the six months ending 30 September 2021 (all figures unaudited):

- 64 cases were completed (23% higher than the 52 case completions in H1 FY21).

- Those 64 cases were settled for an aggregate settlement value of £7.9m.

- The average duration of the 64 cases from the date of signing the investment agreement to the date the case was legally settled was 11.5 months, which is in line with the Company's long-term average.

- The Return on Investment of those 64 cases was 157% which represents a Money Multiple of 2.57x (meaning every £1 Manolete invested into those cases returns £2.57).

- 255 new UK insolvency case enquiries were received, which was 5% higher than the previous six months but 24% below H1 FY21 which was affected far less by the Temporary Measures referred to above.

- 78 new case investments were made (11% lower than the previous six months, which underlines Manolete's high standards of rigorous case assessment and 29% below H1 FY21).

- £4.3m of cash was received from previously completed cases.

50 new UK insolvency case enquiries were received in the month of September 2021, the highest level the Company has experienced since July 2020.

Manolete started the second half of its financial year with 262 live cases in progress.

As at 30 September 2021, Manolete had drawn down £11m from its £25m three-year Revolving Credit Facility with HSBC.

Half year results for the six months ended 30 September 2021 will be announced by the Company next month.

 

Steven Cooklin, CEO of Manolete, commented:

"The Manolete business has performed admirably despite the extraordinary temporary measures enacted by the UK Government designed to suppress UK insolvencies and to support UK employment levels. Effective from the start of this month, those measures have now very largely ended with a return to broadly normal insolvency processes.

"As can be seen from the data released by the UK Insolvency Service, the number of monthly Creditors Voluntary Liquidations had already bounced back to pre-pandemic levels for each of the last four months.

"There is always a time lag between an insolvency appointment, investigation work being done by the Insolvency Practitioner and then cases being referred to Manolete, but we are now starting to see the increased number of insolvency appointments being reflected in our KPIs - September saw the highest level of new case enquiries being received since July 2020. We also witnessed a strong recovery in our numbers of new signed cases at 15 for that month, 50% higher than the previous month. Even with this sharp upturn these KPIs are still far below the level we were experiencing before the Government instigated the necessary economic support measures so we anticipate further strong growth in the number of signed cases in the months ahead.

"With a return to largely normal UK insolvency processes from 1 October 2021, Manolete is well positioned to benefit from that and the likely, widely predicted, increase in insolvency appointments as the economy realigns from the effects of the pandemic".

 

For further information please contact:

 

 

Manolete Partners: 

Steven Cooklin (Chief Executive Officer) via Instinctif Partners

 

Peel Hunt (NOMAD and Broker) +44 (0)20 7418 8900 

James Britton

Rishi Shah

 

Instinctif Partners (Financial PR) manolete@instinctif.com / +44 (0)20 7457 2020

Tim Linacre

George Peele

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVORRAAURRAA
Date   Source Headline
26th Nov 202112:52 pmRNSBlock Listing Application
11th Nov 20217:00 amRNSHalf Year Results
3rd Nov 20217:00 amRNSNotice of Half Year Results
6th Oct 20217:00 amRNSTrading Update
1st Oct 20212:52 pmRNSDirector/PDMR Dealings
22nd Sep 20219:57 amRNSResult of AGM
21st Sep 20217:00 amRNSAGM Statement
9th Jul 20214:30 pmRNSPosting of Annual Report and Notice of AGM
25th Jun 20217:00 amRNSManolete Partners ranked in Band 1 by Chambers
24th Jun 202112:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20217:00 amRNSFull Year Results
23rd Jun 20217:00 amRNSAppointment of Chairman Designate
14th Jun 202110:29 amRNSNotice of Full Year Results
1st Mar 202112:45 pmRNSTR-1: Notification of Major Holdings
23rd Feb 20217:00 amRNSUpdated Investor Presentation
22nd Feb 20217:00 amRNSInvestor Presentation
10th Feb 202111:28 amRNSTR-1: Notification of Major Holdings
10th Feb 20217:00 amRNSDirector/PDMR Dealings
9th Feb 20217:00 amRNSDirector/PDMR Dealings
1st Feb 20217:21 amRNSDirector/PDMR Dealings
29th Jan 20217:00 amRNSDirector/PDMR Dealings
28th Jan 20211:09 pmRNSTR-1: Notification of Major Holdings
28th Jan 202111:24 amRNSTR-1: Notification of Major Holdings
27th Jan 20212:42 pmRNSTR-1: Notification of Major Holdings
26th Jan 20214:40 pmRNSSecond Price Monitoring Extn
26th Jan 20214:35 pmRNSPrice Monitoring Extension
26th Jan 20212:47 pmRNSQ3 Trading Update
5th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Dec 20202:02 pmRNSTR-1: Notification of Major Holdings
18th Nov 202010:29 amRNSLarge Case Update
12th Nov 20207:00 amRNSFurther Significant Case Completion
10th Nov 20207:00 amRNSHalf Year Results
3rd Nov 20202:52 pmRNSNotice of Half Year Results
1st Oct 20207:00 amRNSGrant of Share Options
22nd Sep 202011:51 amRNSResult of AGM
17th Sep 20207:00 amRNSDirector/PDMR Shareholding
15th Sep 20204:23 pmRNSTrading Update - Significant Case Completion
24th Jul 20205:20 pmRNSNotification of Major Holdings
15th Jul 20204:02 pmRNSNotification of Major Holdings
14th Jul 20207:00 amRNSResponse to Article Published by ShareProphets
13th Jul 20204:41 pmRNSSecond Price Monitoring Extn
13th Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20203:46 pmRNSPosting of Annual Report and Notice of AGM
13th Jul 20209:05 amRNSSecond Price Monitoring Extn
13th Jul 20209:00 amRNSPrice Monitoring Extension
3rd Jul 20207:05 amRNSAppointment of Joint Broker
3rd Jul 20207:00 amRNSFull Year Results
30th Jun 20203:56 pmRNSNotice of Full Year Results
29th Jun 202011:08 amRNSUpdate on Judgment
22nd Jun 20207:00 amRNSChange of Date for Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.